Clinical trial
Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases
NCT07143617 is registered in ClinicalTrials.gov with Beijing GoBroad Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study on the Safety of STR-P004 in the Treatment of Patients With Relapsed or Refractory Autoimmune Diseases
- Lead sponsor
- Beijing GoBroad Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 16, 2025
- Completion date
- September 14, 2026
- Enrollment
- 39 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.